Navigation Links
Cardiome Updates Guidance
Date:11/26/2007

ial fibrillation or any other current or future products in our targeted indications; our future operating results are uncertain and likely to fluctuate; we may not be able to raise additional capital; we may not be successful in establishing additional corporate collaborations or licensing arrangements; we may not be able to establish marketing and sales capabilities and the costs of launching our products may be greater than anticipated; we rely on third parties for the continued supply and manufacture of vernakalant (iv) and vernakalant (oral) and we have no experience in commercial manufacturing; we may face unknown risks related to intellectual property matters; we face increased competition from pharmaceutical and biotechnology companies; and other factors as described in detail in our filings with the Securities and Exchange Commission available at http://www.sec.gov and the Canadian securities regulatory authorities at http://www.sedar.com. Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements and information, which are qualified in their entirety by this cautionary statement. All forward-looking statements and information made herein are based on our current expectations and we undertake no obligation to revise or update such forward-looking statements and information to reflect subsequent events or circumstances, except as required by law.

CONTACT: Peter K. Hofman, Senior Director, Investor Relations, (604) 676-6993 or Toll Free: 1-800-330-9928, Email: phofman@cardiome.com


'/>"/>
SOURCE Cardiome Pharma Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Cardiome to Present at Bear Stearns Conference
2. Cardiome to Present at ThinkEquity Conference
3. Cardiome to Present at CIBC Conference
4. Cardiome To Release Third Quarter Results
5. Cardiome Initiates Phase 1 Study for GED-aPC
6. FDA Updates Prescription Guidelines for Blood Thinner
7. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
8. Cardinal Health Reaffirms Fiscal 2008 EPS Guidance, Updates Segment Profit Outlook
9. MedQuist Updates Status of Outstanding SEC Filings
10. Sunrise Provides Status Report on Special Independent Committee Investigation; Provides Updates on Managements Internal Control Review Efforts and on Legal Proceedings
11. ADA Updates Environmental Recommendations for Handling Waste
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... ... July 02, 2015 , ... It’s no secret that what we consume can have an effect on the body. ... easily feel dehydrated or perhaps even undernourished if not eating enough of the right foods, as ... an easy time of year to overdo it on the food front as well, with sweet ...
(Date:7/2/2015)... ... 2015 , ... Cs &A, the leader in Semi Timing ... and publication of their newest offering to complement the existing line of Market ... Designed in support of coverage for the full spectrum of Semi Timing solutions ...
(Date:7/1/2015)... ... July 01, 2015 , ... In the United States, summer ... many Middle-Eastern countries like Saudi Arabia and Dubai, the summer temperatures are so hot, ... climates. Celebrity dentist Dr. Sam Saleh of ORA Dentistry Spa notes that a trip ...
(Date:7/1/2015)... , ... July 01, 2015 , ... ... the manufacturers of Levaquin ( http://www.injurybeacon.com/levaquin/lawsuit/ ) has granted the Defendants’ Motion for ... District of West Virginia on June 26th, the Court rejected the Plaintiff’s ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... ... retail, long term care, specialty, combo, and compounding pharmacy operations, announces the most ... to the Cardinal Health RBC event at the Venetian Las Vegas, ...
Breaking Medicine News(10 mins):Health News:Iryna Lobur Shares Healthy Treats to Eat for Summer 2Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 2Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 3Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 4Health News:Dr. Sam Saleh Invites Vacationing International Patients to Get a Same-Day Hollywood Smile During the July Travel Season 2Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 2Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 3Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 2Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 3Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 4
... (MEMPHIS, Tenn. December 10, 2011) Symptoms improved significantly ... a single treatment with gene therapy developed by researchers ... demonstrated to be safe in a clinical trial conducted ... The findings of the six-person study mark the ...
... , FRIDAY, Dec. 9 (HealthDay News) -- ... days after giving birth have an increased risk of ... Researchers examined data from more than 120,000 Danish women ... psychiatric care either as an outpatient or an inpatient ...
... 9 (HealthDay News) -- Many American soldiers who suffer burns ... or rapid decline in kidney function that is potentially deadly. ... acute kidney injury among 692 U.S. military casualties who were ... two different classification systems, the researchers found that rates of ...
... new partnership between the Centre for Reviews and Dissemination ... is launched today., PubMed Health is a new online ... (NCBI) at the US National Library of Medicine (NLM) ... summaries and full text of selected systematic reviews and ...
... BOSTON Cancer of the liver rare in the ... can result from environmental exposures or infections like chronic ... at Dana-Farber Cancer Institute have identified a mechanism in mice ... into cancerous ones. In addition, they demonstrated in a ...
... Premature infants have fewer types of bacteria in their stomachs ... However, the bacteria and other microbes often found in preemies, ... Duke University Medical Center noted. "You see diversity emerge ... to be stuck -- they have fewer types of bacteria ...
Cached Medicine News:Health News:Gene therapy achieves early success against hereditary bleeding disorder 2Health News:Gene therapy achieves early success against hereditary bleeding disorder 3Health News:Psych Episode Near Childbirth May Presage Bipolar Disorder 2Health News:Burn-Casualty Soldiers at High Risk for Kidney Injury, Study Finds 2Health News:Researchers identify a novel therapeutic approach for liver cancer 2Health News:Preemies Infected With More Dangerous Types of Bacteria: Study 2
(Date:7/1/2015)... The Coalition of State Rheumatology Organizations ... professional rheumatology societies, today released the findings of ... of biosimilars and the potential impact of these ... are medicines that are highly similar, but not ... from generic medications in that it is impossible ...
(Date:7/1/2015)... 2015 Research ... addition of the "2015 New Frontiers ... Business Challenges, Emerging Technologies, Competitive Landscape" ... New Frontiers in European Clinical Chemistry and ... Landscape is a new five-country strategic analysis ...
(Date:7/1/2015)... , June 24, 2015 ... announced the addition of the "2015 Strategies ... their offering. This new 175-page report ... segments, including diabetes (strips and meters), pregnancy, ovulation, ... size, growth, regulatory requirements, technologies, and competitive profiles. ...
Breaking Medicine Technology:Survey Of Rheumatologists Nationwide Regarding Biosimilars Highlights Need For More Robust FDA Standards 22015 New Frontiers in European Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape 22015 Strategies in the Home/Self Testing Market 2
... p.m. Eastern Time - SOUTH SAN FRANCISCO, Calif., May ... ), a biopharmaceutical company focused on oncology, today reported ... 2009, and provided a corporate update. "The completion of ... picoplatin for the second-line treatment of small cell lung ...
... Burden of RSV Disease Presented at Pediatric Academic ... announced results from a recent study it sponsored, ... in Oakland, CA, assessing risk factors for respiratory ... infants born at 33 weeks gestational age [GA] ...
Cached Medicine Technology:Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 2Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 3Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 4Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 5Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 6Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 7Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 8Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 9MedImmune Presents New Data Demonstrating Increased Risk for Medically Attended RSV in Late-Preterm Infants 2MedImmune Presents New Data Demonstrating Increased Risk for Medically Attended RSV in Late-Preterm Infants 3
... Collar and Stabilizer Plastazote® with ... Hook-and-pile closure straps. Chin cradle ... pieces may be interchanged for ... to the standard Philadelphia Collar ...
Urethrotome - non-optical...
Optical Urethrotome for Telescope 2.7 mm for children....
... The USA Elite ... Visual Urethrotomes are utilized ... strictures and bladder neck ... The visual obturator converts ...
Medicine Products: